MediciNova, Inc. (MNOV)
1.59
-0.04
(-2.45%)
USD |
NASDAQ |
Feb 11, 16:00
1.60
+0.01
(+0.63%)
After-Hours: 20:00
MediciNova EPS Diluted (Quarterly) : -0.0622 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | -0.1279 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.050M |
| Revenue (Quarterly) | 0.1233M |
| Total Expenses (Quarterly) | 3.174M |
| Enterprise Value | 45.84M |
| Gross Profit Margin (Quarterly) | -31.63% |
| Profit Margin (Quarterly) | -2.47K% |
| Earnings Yield | -15.40% |
| Normalized Earnings Yield | -15.40 |